SkyTides: Insulet’s President Provided ‘Critical Misinformation To Investors’

SkyTides on Friday continued its assault Friday on Insulet Corporation PODD 0.21% by releasing yet another report containing allegations of deceptive behavior within the company. The new report focuses on information that Insulet’s president Shacey Petrovic supplied to shareholders.

SkyTides believes Petrovic mislead shareholders by misrepresenting the threat that Medtronic PLC MDT 1.78%’s recently-approved 670G insulin pump poses to Insulet’s business.

SkyTides takes objection to the following quote that Petrovic made on a recent conference call with investors:

“As we’ve stated many times, we are laser-focused on new patient starts coming from multiple daily injection patients, not from patients already using competitive pump…our messaging is focused on the multiple daily injection patients. That is no where 670G is focused.”

SkyTides followed up with a conversation with Medtronic’s diabetes consultant team to confirm the 670G’s target market.

“Absolutely all of our insulin pump devices are marketed toward anyone who is using insulin,” one team member told SkyTides. “So that includes, obviously, Type 1s but also Type 2s whose medication no longer works and are using insulin in an injectable form.”

SkyTides also asked a member of Medtronic’s investor relations team whether the company expects to target new patients with the 670G or take market share from competitors. The representative confirmed…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!